Absci (ABSI) Competitors $2.61 -0.08 (-2.97%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$2.61 +0.00 (+0.15%) As of 09/19/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABSI vs. DFIN, GB, WLDN, GDRX, PHR, UPBD, PLTK, PRG, STGW, and CTOSShould you be buying Absci stock or one of its competitors? The main competitors of Absci include Donnelley Financial Solutions (DFIN), Global Blue Group (GB), Willdan Group (WLDN), GoodRx (GDRX), Phreesia (PHR), Upbound Group (UPBD), Playtika (PLTK), Aaron's (PRG), Stagwell (STGW), and Custom Truck One Source (CTOS). These companies are all part of the "business services" industry. Absci vs. Its Competitors Donnelley Financial Solutions Global Blue Group Willdan Group GoodRx Phreesia Upbound Group Playtika Aaron's Stagwell Custom Truck One Source Donnelley Financial Solutions (NYSE:DFIN) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Is DFIN or ABSI more profitable? Donnelley Financial Solutions has a net margin of 10.87% compared to Absci's net margin of -2,737.94%. Donnelley Financial Solutions' return on equity of 20.03% beat Absci's return on equity.Company Net Margins Return on Equity Return on Assets Donnelley Financial Solutions10.87% 20.03% 10.17% Absci -2,737.94%-60.21%-50.85% Do analysts rate DFIN or ABSI? Donnelley Financial Solutions presently has a consensus target price of $71.33, indicating a potential upside of 34.06%. Absci has a consensus target price of $7.98, indicating a potential upside of 205.67%. Given Absci's higher probable upside, analysts plainly believe Absci is more favorable than Donnelley Financial Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Donnelley Financial Solutions 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Absci 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders have more ownership in DFIN or ABSI? 93.8% of Donnelley Financial Solutions shares are owned by institutional investors. Comparatively, 52.1% of Absci shares are owned by institutional investors. 4.3% of Donnelley Financial Solutions shares are owned by insiders. Comparatively, 10.5% of Absci shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, DFIN or ABSI? Donnelley Financial Solutions has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, Absci has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Does the media refer more to DFIN or ABSI? In the previous week, Absci had 1 more articles in the media than Donnelley Financial Solutions. MarketBeat recorded 3 mentions for Absci and 2 mentions for Donnelley Financial Solutions. Donnelley Financial Solutions' average media sentiment score of 1.73 beat Absci's score of 0.17 indicating that Donnelley Financial Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Donnelley Financial Solutions 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Absci 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation & earnings, DFIN or ABSI? Donnelley Financial Solutions has higher revenue and earnings than Absci. Absci is trading at a lower price-to-earnings ratio than Donnelley Financial Solutions, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDonnelley Financial Solutions$781.90M1.87$92.40M$2.8318.80Absci$4.53M86.15-$103.11M-$0.94-2.78 SummaryDonnelley Financial Solutions beats Absci on 9 of the 15 factors compared between the two stocks. Get Absci News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABSI vs. The Competition Export to ExcelMetricAbsciMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$390.26M$3.14B$5.77B$10.45BDividend YieldN/A2.35%5.61%4.57%P/E Ratio-2.7820.9180.5026.82Price / Sales86.15262.05456.1891.97Price / CashN/A46.4637.6661.43Price / Book1.679.6015.756.39Net Income-$103.11M-$53.22M$3.30B$271.80M7 Day Performance2.35%3.11%5.35%3.51%1 Month Performance1.95%6.23%7.28%9.58%1 Year Performance-39.58%11.02%80.79%28.53% Absci Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABSIAbsci2.3531 of 5 stars$2.61-3.0%$7.98+205.7%-39.6%$390.26M$4.53M-2.78210High Trading VolumeDFINDonnelley Financial Solutions3.2476 of 5 stars$53.81-1.6%$71.33+32.6%-20.6%$1.50B$781.90M19.011,800Positive NewsGBGlobal Blue Group0.6719 of 5 stars$7.49+0.1%$6.00-19.9%+35.4%$1.49B$545.29M20.241,410WLDNWilldan Group4.3155 of 5 stars$98.74-2.2%$111.50+12.9%+156.7%$1.48B$565.80M41.311,761Positive NewsShort Interest ↑GDRXGoodRx3.6861 of 5 stars$4.08-2.6%$5.80+42.2%-40.2%$1.46B$792.32M40.80950Positive NewsShort Interest ↑PHRPhreesia4.292 of 5 stars$23.38-3.3%$34.08+45.8%+1.3%$1.45B$419.81M-55.672,082Trending NewsUPBDUpbound Group4.4973 of 5 stars$27.07+8.2%$36.00+33.0%-12.4%$1.45B$4.32B15.2111,970Dividend AnnouncementAnalyst ForecastHigh Trading VolumePLTKPlaytika3.8542 of 5 stars$3.58-4.5%$6.66+85.9%-56.0%$1.41B$2.55B14.923,500PRGAaron's3.5819 of 5 stars$35.550.0%$41.00+15.3%-28.3%$1.41B$2.46B7.031,403Positive NewsSTGWStagwell3.6292 of 5 stars$5.31+1.5%$8.17+53.9%-29.5%$1.35B$2.84B11.1314,607News CoverageCTOSCustom Truck One Source1.3322 of 5 stars$5.77+1.0%$6.38+10.6%+55.2%$1.29B$1.80B-36.031,800Positive News Related Companies and Tools Related Companies Donnelley Financial Solutions Competitors Global Blue Group Competitors Willdan Group Competitors GoodRx Competitors Phreesia Competitors Upbound Group Competitors Playtika Competitors Aaron's Competitors Stagwell Competitors Custom Truck One Source Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABSI) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Absci With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
